Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Announcements
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • Announcements

Editor-in-Chief: Giuseppe Leone | Italy

2.3
Impact Factor 2025
3.2
CiteScore 2025
2.3
Impact Factor 2025
3.2
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • Efficacy and safety of teclistamab followed by autologous stem cells transplant in functional high-risk and triple class refractory multiple myeloma

    Vincenzo Sammartano, Sara Ciofini, Beatrice Esposito Vangone, Chiara Carrara, Monica Bocchia, Alessandro Gozzetti
    e2025051
    2025-06-29
    https://doi.org/10.4084/MJHID.2025.051
    824
    PDF: 639
    HTML: 60
  • NEW THERAPEUTIC OPTIONS FOR THE TREATMENT OF SICKLE CELL DISEASE Guest Editor: Raffaella Origa

    Alessandro Matte, Filippo Mazzi, Enrica Federti, Oliviero Olivieri, Lucia De Franceschi
    e2019002
    2019-01-01
    https://doi.org/10.4084/mjhid.2019.002
    7149
    PDF: 3799
    HTML: 840
  • FDG-PET SCAN: A NEW PARADIGM FOR FOLLICULAR LYMPHOMA MANAGEMENT.

    Andrea Gallamini, Anna Borra
    e2017029
    2017-04-15
    https://doi.org/10.4084/mjhid.2017.029
    3423
    PDF: 1334
    HTML: 2373
  • CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL

    Ugo Testa, Dr. Elvira Pelosi, Dr. Germana Castelli, Dr. Alberto Fresa, Prof. Luca Laurenti
    e2024045
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.045
    3906
    PDF: 1706
    HTML: 104
  • CYTOMEGALOVIRUS REACTIVATION IN ADULT RECIPIENTS OF AUTOLOGOUS STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE

    omar ziad alrawi, fawzi abdel-latif abdel-rahman, rula alnajjar, husam abujazar, mourad salam, mustafa saad
    e2015049
    2015-08-25
    https://doi.org/10.4084/mjhid.2015.049
    1610
    PDF: 957
    HTML: 1025
    figures: 228
    table 1: 229
    table2: 232
    table3: 234
  • HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR PAEDIATRIC PATIENTS WITH X-LINKED LYMPHOPROLIFERATIVE SYNDROME

    Yuan Sun
    e2024036
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.036
    1424
    PDF: 1223
    HTML: 199
  • THE BROAD-RANGING PANORAMA OF SYSTEMIC AUTOINFLAMMATORY DISORDERS WITH SPECIFIC FOCUS ON ACUTE PAINFUL SYMPTOMS AND HEMATOLOGIC MANIFESTATIONS IN CHILDREN

    Donato Rigante
    e2018067
    2018-10-30
    https://doi.org/10.4084/mjhid.2018.067
    2247
    PDF: 1379
    HTML: 1138
  • EVOLVİNG PARADİGMS İN THE MANAGEMENT OF PRİMARY IMMUNE THROMBOCYTOPENİA İN ADULTS: FROM CORTİCOSTEROİDS TO TARGETED BİOLOGİC THERAPİES

    Massimo Martino, Laura Giordano, Maria Bruna Greve, Violetta Marafioti, Caterina Alati
    e2026067
    2026-09-01
    https://doi.org/10.4084/MJHID.2026.067
    239
    PDF: 232
    Html: 43
  • REAL WORLD MULTIPLE MYELOMA REGISTRY FROM JORDAN, A DEVELOPING COUNTRY.

    Abdalla Awidi, Farah Qasem, A'sem Abu-Qamar, Batool Aqel, Rand Aladayleh, Ilham Alteerah, Ahmad Magableh, , Hisham Bawa”neh, Feras Al-fararjeh
    e2022031
    2022-04-28
    https://doi.org/10.4084/MJHID.2022.031
    1433
    PDF: 822
    HTML: 424
  • Acute Panmyelosis with Myelofibrosis - A Rare Subtype of Acute Myeloid Leukemia

    Tathagata Chatterjee, Srishti Gupta, Ajay Sharma, Sanjeevan Sharma, Devika Gupta
    e2013042
    2013-06-04
    https://doi.org/10.4084/mjhid.2013.042
    3456
    PDF: 1033
    HTML: 3178
    flowcytometric result of peripheral blood sample: 239
  • PEDIATRIC HODGKIN LYMPHOMA IN LOW- and MIDDLE-INCOME COUNTRIES (LMICs). A NARRATIVE REVIEW Pediatric Hodgkin's lymphoma in low-income countries

    Dr, Moleti, Anna Maria Testi
    e2024078
    2024-10-31
    https://doi.org/10.4084/MJHID.2024.078
    1386
    PDF: 968
    HTML: 346
  • PATHOPHISIOLOGY OF SICKLE CELL DISEASE AND NEW DRUGS FOR THE TREATMENT

    Lucia De Franceschi
    e2009024
    2009-12-26
    1157
    PDF: 686
    HTML: 11193
  • PROGNOSTIC VALUE OF PROTEASE ACTIVATED RECEPTOR-1 IN EGYPTIAN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA

    Adel Abd Elhaleim Hagag
    e2014029
    2014-04-06
    https://doi.org/10.4084/mjhid.2014.029
    1460
    PDF: 864
    HTML: 2381
  • CD146 MOLECULE EXPRESSION IN B CELLS ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALLs): A FLOW- CYTOMETRIC MARKER FOR AN ACCURATE DIAGNOSTIC WORK-UP

    Alessandro Laganà, Matteo Totaro, Maria Laura Bisegna, Loredana Elia, Stefania Intoppa, Marco Beldinanzi, Mabel Matarazzo, Mariangela di Trani, Alessandro Costa, Raffaele Maglione, Biancamaria Mandelli, Sabina Chiaretti, Maurizio Martelli, Maria Stefania De Propris
    e2024064
    2024-08-31
    https://doi.org/10.4084/MJHID.2024.064
    1388
    PDF: 867
    Suppl. Files: 504
    Html: 128
  • CD56+/CD38+ Neutrophils: Rapid and Specific Flow Cytometric Signature for Chronic Myeloid Leukemia

    Alessandro Laganà, Matteo Breccia, Loredana Elia, Emilia Scalzulli, Maria Laura Bisegna, Claudia Ielo, Sonia Buffolino, Attilio Di Lascio, Concetta Anna Germano, Stefania Intoppa, Maria Laura Milani, Maurizio Martelli, Massimo Breccia, Maria Stefania De Propris
    2026-04-30
    https://doi.org/10.4084/MJHID.2026.049
    344
    PDF: 343
    Suppl. Files: 77
    HTML: 75
  • POOR HEMOPOIETIC STEM CELL MOBILIZERS IN MULTIPLE MYELOMA : A SINGLE INSTITUTION EXPERIENCE

    Guillermo Jose Ruiz-Delgado, Avril Lopez-Otero, Ana Hernandez-Arizpe, Aura Ramirez-Medina, Guillermo Jose Ruiz-Argüelles
    e2010016
    2010-06-19
    https://doi.org/10.4084/mjhid.2010.016
    1232
    PDF: 822
    HTML: 598
  • Treatment of relapsed/refractory CLL with Venetoclax-Rituximab during the COVID-19 pandemic: A daily-life experience in southern Italy.

    Stefano Molica, Paolo Sportoletti, Nicola Di Renzo, Pellegrino Musto, Fabrizio Pane, Francesco Di Raimondo
    e2021042
    2021-06-28
    https://doi.org/10.4084/MJHID.2021.042
    1551
    PDF: 560
    HTML: 241
  • RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA: CHEMOIMMUNOTHERAPY, TREATMENT UNTIL PROGRESSION WITH MECHANISM-DRIVEN AGENTS OR FINITE-DURATION THERAPY?

    Antonio Cuneo, Robin Foà
    e2019024
    2019-02-27
    https://doi.org/10.4084/mjhid.2019.024
    2840
    PDF: 1728
    HTML: 400
  • INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?

    Francesco Zallio, Giulia Limberti, Marco Ladetto
    e2017035
    2017-05-01
    https://doi.org/10.4084/mjhid.2017.035
    3408
    PDF: 1103
    HTML: 2504
  • AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR HIGH-RISK ACUTE LYMPHOBLASTIC LEUKEMIA: NON-RANDOMIZED STUDY WITH A MAXIMUM FOLLOW-UP OF MORE THAN 22 YEARS

    Grzegorz Helbig, Malgorzata Krawczyk-Kulis, Malgorzata Kopera, Krystyna Jagoda, Patrycja Rzepka, Aleksandra Majewska-Tessar, Marta Hejla, Slawomira Kyrcz-Krzemien
    e2014047
    2014-06-29
    https://doi.org/10.4084/mjhid.2014.047
    1636
    PDF: 965
    HTML: 2014
    Figure: 215
    Tables: 226
    ALL revision 1: 315
    response to reviewer: 221
  • AUTOLOGOUS STEM CELL TRANSPLANTATION FOR AGGRESSIVE LYMPHOMAS

    Giuseppe Visani, Paola Picardi, Patrizia Tosi, Alessandro Isidori
    e2012075
    2012-11-07
    https://doi.org/10.4084/mjhid.2012.075
    2723
    PDF: 932
    HTML: 2139
  • PROGNOSTIC SIGNIFICANCE AND TREATMENT IMPLICATIONS OF MINIMAL RESIDUAL DISEASE STUDIES IN PHILADELPHIA-NEGATIVE ADULT ACUTE LYMPHOBLASTIC LEUKEMIA

    Orietta Spinelli, Manuela Tosi, Barbara Peruta, Marie Lorena Guinea Montalvo, Elena Maino, Anna Maria Scattolin, Margherita Parolini, Piera Viero, Alessandro Rambaldi, Renato Bassan
    e2014062
    2014-08-28
    https://doi.org/10.4084/mjhid.2014.062
    2497
    PDF: 1166
    HTML: 5208
  • THE ROLE OF SLC22A4 IN ACUTE MYELOID LEUKEMIA

    Yingying Li, Yang Li, Wenguo Cheng
    e2025073
    2025-10-31
    https://doi.org/10.4084/MJHID.2025.073
    596
    PDF: 296
    HTML: 147
  • Peripheral Red Blood Cell Split Chimerism as a Consequence of Intramedullary Selective Apoptosis of Recipient Red Blood Cells in a Case of Sickle Cell Disease

    Marco Marziali, Antonella Isgrò, Pietro Sodani, Javid Gaziev, Daniela Fraboni, Katia Paciaroni, Cristiano Gallucci, Cecilia Alfieri, Andrea Roveda, Gioia De Angelis, Luisa Cardarelli, Michela Ribersani, Marco Andreani, Guido Lucarelli
    e2014066
    2014-08-28
    https://doi.org/10.4084/mjhid.2014.066
    1758
    PDF: 1060
    HTML: 1896
    Untitled: 239
    Untitled: 220
  • HEMATOPOIETIC STEM CELL TRANSPLANTATION IN EGYPT CHALLENGES AND OPPORTUNITIES

    Hossam Kamel Mahmoud, Gamaleldin Mohamed Fathy, Alaa Elhaddad, Omar Abdelrahman Fahmy, Mohamed Abdelmooti, Raafat Abdelfattah, Mahmoud Tarek Sayed Ahmed Bokhary
    e2020023
    2020-04-27
    https://doi.org/10.4084/mjhid.2020.023
    1996
    PDF: 1048
    HTML: 883
  • LIMITED STAGE FOLLICULAR LYMPHOMA: THE ROLE OF RADIATION THERAPY.

    Andrea Riccardo Filippi
    e2016041
    2016-09-01
    https://doi.org/10.4084/mjhid.2016.041
    3867
    PDF: 1170
    HTML: 2491
    Figure 1: 243
  • CLASSIC KSHV/HHV-8-POSITIVE PRIMARY EFFUSION LYMPHOMA (PEL): A SYSTEMATIC REVIEW AND META-ANALYSIS OF CASE REPORTS

    Ilaria Cozzi, Giovanni Rossi, Emma Rullo, Valeria Ascoli
    e2022020
    2022-02-27
    https://doi.org/10.4084/MJHID.2022.020
    1705
    PDF: 1026
    HTML: 445
  • Lymphomatoid Granulomatosis of Central Nervous System and Lung Driven by Epstein Barr Virus Proliferation: Successful Treatment with Rituximab

    Ruben Fernandez, Esther Gonzalez, Almudena Fernandez, Ana Pilar Gonzalez, Juan Manuel Sancho, Francisco Dominguez, Carmen Fernandez
    e2014017
    2014-02-16
    https://doi.org/10.4084/mjhid.2014.017
    1724
    PDF: 966
    HTML: 3198
    Figure 5: 193
    Figure 4: 194
    Figure 3: 229
    Figure 1: 209
    Figure 2: 205
  • IMPACT OF PRETRANSPLANT DONOR AND RECIPIENT CYTOMEGALOVIRUS SEROSTATUS ON OUTCOME FOR MULTIPLE MYELOMA PATIENTS UNDERGOING REDUCED INTENSITY CONDITIONING ALLOGENEIC STEM CELL TRANSPLANTATION.

    Jean Elcheikh
    e2013026
    2013-04-10
    https://doi.org/10.4084/mjhid.2013.026
    1387
    PDF: 782
    HTML: 1492
  • EXPRESSION AND CLINICAL CORRELATION OF PD-1/PD-L1 AND VE1(BRAFP.V600E) IN PEDIATRIC LANGERHANS CELL HISTIOCYTOSIS

    sneha tandon, Sheila Weitzman , Brooklyn Joyce, Bryan Maguire, Derek Stephens, James Whitlock, Cynthia Hawkins , Bo-Yee Ngan, Oussama Abla
    e2023035
    2023-04-27
    https://doi.org/10.4084/MJHID.2023.035
    1415
    PDF: 1007
    HTML: 300
  • Bone marrow involvement in a patient with alpha heavy chain disease:Response to tetracycline treatment

    Zahit Bolaman, Irfan Yavasoglu, Gokhan Sargin, Gurhan Kadikoylu, Firuzan Kacar Doger
    e2012034
    2012-05-07
    https://doi.org/10.4084/mjhid.2012.034
    1336
    PDF: 1076
    HTML: 3428
  • EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES

    Pietro Tralongo, Arianna Bakacs, Luigi Maria Larocca
    e2024042
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.042
    4658
    PDF: 1808
    HTML: 1308
  • CLINICAL USEFULNESS OF BROCHOALVEOLAR LAVAGE IN THE MANAGEMENT OF PULMONARY INFILTRATES IN ADULTS WITH HAEMATOLOGICAL MALIGNANCIES AND STEM CELL TRANSPLANTATION

    Laura Jorge, Diego Torres, Agustín Languasco, Pablo Rodriguez, Pablo Bonvehí, Elena Temporiti, Silvia Relloso, Cristina Videla, Fabián Herrera
    e2020025
    2020-05-01
    https://doi.org/10.4084/mjhid.2020.025
    9682
    PDF: 844
    HTML: 281
  • A case of fatal hyperammonaemic encephalopathy in a patient with end-stage Multiple Myeloma treated with daratumumab

    Mauro Passucci, Francesca Fazio, Maria Teresa Petrucci
    e2023012
    2023-01-01
    https://doi.org/10.4084/MJHID.2023.012
    1100
    PDF: 1014
    HTML: 428
  • THE TREATMENT OF ADVANCED-STAGE MYCOSIS FUNGOIDES AND SEZARY SYNDROME: A HEMATOLOGIST'S POINT OF VIEW.

    Antonio Giordano, Livio Pagano
    e2022029
    2022-02-27
    https://doi.org/10.4084/MJHID.2022.029
    2550
    PDF: 1106
    HTML: 410
  • INFECTIOUS AETIOLOGY OF MARGINAL ZONE LYMPHOMA AND ROLE OF ANTI-INFECTIVE THERAPY

    Salvatore Perrone, Gianna Maria D'Elia, Alessandro Pulsoni
    e2016006
    2016-01-01
    https://doi.org/10.4084/mjhid.2016.006
    4713
    PDF: 1419
    HTML: 2236
  • AUTOLOGOUS STEM CELL TRANSPLANTATION IN ELDERLY ACUTE MYELOID LEUKEMIA

    Gert J. Ossenkoppele, Jeroen J.W.M. Janssen, Peter C. Huijgens
    e2013018
    2013-02-16
    https://doi.org/10.4084/mjhid.2013.018
    2559
    PDF: 892
    HTML: 3287
  • LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML

    Xavier Thomas, Marica Laurino, sandrine loron, marie-virginie larcher, gaëlle fossard, mohamed elhamri, alexandre deloire, marie balsat, fiorenza barraco, hélène labussière, sophie ducastelle, myriam renault, eric wattel, maël heiblig, gilles salles
    e2020020
    2020-04-27
    https://doi.org/10.4084/mjhid.2020.020
    1995
    PDF: 1232
    HTML: 346
  • A rare immune-related mesenteric and retroperitoneal serositis in a multirefractory Hodgkin lymphoma patient successfully treated with chylolymphostatic surgery

    Matteo D'Addona, Luca Pezzullo, Corradino Campisi, Corrado Cesare Campisi, Valentina Giudice, Vincenzo Ciccone, Roberto Guariglia, Bianca Serio, Carmine Selleri
    e2023063
    2023-10-30
    https://doi.org/10.4084/MJHID.2023.063
    763
    PDF: 473
    HTML: 168
  • Molecular Expression of bone marrow angiogenic factors, cell-cell adhesion molecules and matrix-metallo-proteinase plasma cellular disorders: a molecular panel to investigate disease progression

    Maria Cristina Rapanotti
    e2018059
    2018-10-30
    https://doi.org/10.4084/mjhid.2018.059
    1427
    PDF: 851
    HTML: 211
  • REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy

    Ulrike Bacher, Simon Brechbühl, Barbara Jeker, Thomas Pabst
    e2021012
    2021-01-01
    https://doi.org/10.4084/mjhid.2021.012
    1719
    PDF: 782
    HTML: 1501
  • TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity

    Ugo Testa, Dr. Germana Castelli, Dr. Elvira Pelosi, Dr. Galli, Prof. Patrizia Chiusolo
    e2025039
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.039
    2647
    PDF: 1788
    HTML: 698
  • MANAGING INVASIVE FUNGAL INFECTIONS DURING ALLOGENEIC HEMATOPOIETIC TRANSPLANTATION: A 2025 UPDATE

    Martina Quattrone, Alessia Di Pilla, Sara Brunetti, Antonio Giordano, Luana Fianchi, Livio Pagano, Marianna Criscuolo
    e2025064
    2025-08-31
    https://doi.org/10.4084/MJHID.2025.064
    2665
    PDF: 1044
    HTML: 322
  • DIAGNOSIS OF MALARIA INFECTION WITH OR WITHOUT DISEASE

    Zeno Bisoffi, Federico Gobbi, Dora Buonfrate, Jef Van den Ende
    e2012036
    2012-05-09
    https://doi.org/10.4084/mjhid.2012.036
    3746
    PDF: 1181
    HTML: 23382
  • Systemic lupus erythematosus, complicated by nephritis and macrophage activation syndrome, not responsive to high-dose immunosuppression

    Ioanna Saougou, Alexandros Makis
    e2026054
    2026-06-30
    https://doi.org/10.4084/MJHID.2026.054
    324
    PDF: 249
    HTML: 83
  • Chronic-graft-versus-host-disease-related polymyositis: a 17-months-old child with a rare and late complication of haematopoietic stem cell transplantation.

    Matteo Chinello, Rita Balter, Massimiliano De Bortoli, Virginia Vitale, Ada Zaccaron, Elisa Bonetti, Paola Tonin, Gaetano Vattemi, Valeria Guglielmi, Simone Cesaro
    e2020002
    2020-01-01
    https://doi.org/10.4084/mjhid.2020.002
    1871
    PDF: 1119
    HTML: 328
  • BCR SIGNALING INHIBITORS: AN OVERVIEW OF TOXICITIES ASSOCIATED WITH IBRUTINIB AND IDELALISIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

    Lorenzo Falchi, Jessica M Baron, Carrie Anne Orlikowski, Alessandra Ferrajoli
    e2016011
    2016-02-10
    https://doi.org/10.4084/mjhid.2016.011
    4467
    PDF: 1553
    HTML: 3737
  • Focusing On A Unique Innate Memory Cell Population Of Natural Killer Cells In The Fight Against COVID-19: Harnessing The Ubiquity Of Cytomegalovirus Exposure Memory Cell Population Of Natural Killer Cells in COVID-19 and Cytomegalovirus Exposure

    SUPARNO CHAKRABARTI
    e2020047
    2020-06-28
    https://doi.org/10.4084/mjhid.2020.047
    1326
    PDF: 995
    HTML: 352
  • Epstein-Barr Virus (EBV)-associated Haemophagocytic Syndrome

    Lorenza Torti, Luigi Maria Larocca, Giuseppina Massini, Luciana Teofili
    e2012008
    2012-01-25
    https://doi.org/10.4084/mjhid.2012.008
    1951
    PDF: 900
    HTML: 1656
  • PROGNOSTIC IMPACT OF IMMUNOHISTOCHEMICAL P53 EXPRESSION IN BONE MARROW BIOPSY IN HIGHER RISK MDS: A PILOT STUDY

    Alfredo Molteni, Emanuele Ravano, Marta Riva, Michele Nichelatti, Laura Bandiera, Lara Crucitti, Mauro Truini, Roberto Cairoli
    e2019015
    2019-02-26
    https://doi.org/10.4084/mjhid.2019.015
    1972
    PDF: 1035
    HTML: 353
101 - 150 of 175 items << < 1 2 3 4 > >> 
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.